Article Information
PubMed
Published By
History
- Received October 27, 2020
- Accepted November 2, 2020
- Published online January 13, 2021.
Copyright & Usage
Copyright © 2021 American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- Richard M. Longnecker, Editor, Northwestern University
Article Versions
- Accepted Manuscript version (November 11, 2020).
- You are viewing the most recent version of this article.
Author Information
- Lindsey B. Crawforda,
- Meaghan H. Hancocka,
- Hillary M. Struthersa,
- Daniel N. Streblowa,
- Andrew D. Yurochkob,
- Patrizia Caposioa,
- Felicia D. Goodrumc and
- Jay A. Nelsona
- aVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA
- bDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
- cDepartment of Immunobiology, BIO5 Institute, University of Arizona, Tucson, Arizona, USA
- Address correspondence to Jay A. Nelson, nelsonj{at}ohsu.edu.
Citation Crawford LB, Hancock MH, Struthers HM, Streblow DN, Yurochko AD, Caposio P, Goodrum FD, Nelson JA. 2021. CD34+ hematopoietic progenitor cell subsets exhibit differential ability to maintain human cytomegalovirus latency and persistence. J Virol 95:e02105-20. https://doi.org/10.1128/JVI.02105-20.